Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A.
Journal Information
Full Title: Mar Drugs
Abbreviation: Mar Drugs
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"gel bands were then excised from the gel and submitted to trypsin digestion for the next bottom-up nano-esi-uplc-ms/ms analysis (data available via proteomexchange with identifier pxd048098).; the mass spectrometry proteomics data have been deposited to the proteomexchange consortium via the pride [ ] partner repository with the data set identifier pxd048098.; supplementary materials the following supporting information can be downloaded at: https://www mdpi com/article/10 3390/md22010041/s1 figure s1: list of transitions of usp5 tryptic peptides selected for the analysis of the lip experiment; figure s2: usp5 peptides identified with the lip experiment involved in binding with gea; figure s3: binding mode of hhy (in violet) superimposed to its pose (in green) in the crystal structure of usp5 (pdb code: 6dxt); figure s4: uncropped image displaying the gel related to one of the darts experiments; figure s5: uncropped image of the western blot confirmation of darts experiments; figure s6: darts data for usp5; figure s7: peak area of peptide transition analyzed in the t-lip experiments; figure s8: plot of the ru values obtained through spr analysis in function of gea concentrations [ 16 19 20 21 22 ]."
"Conflicts of Interest The authors declare no conflicts of interest."
"This research was funded by the University of Salerno (FARB 2021) ORSA215145 project, and by Ministero dell’Università e della Ricerca (MUR)—PRIN2022 project, “2022RCTY7M, BiTMaP: Coupling the power of bioinformatics and experimental tools for accelerating the production, structural elucidation, and target identification of marine natural products” and PRIN2022-PNRR project, “P2022CKMPW, TACSI Driver: a multitasks platform to guide the Target identification, Assessment of the binding, Collection of natural products from waste, Synthesis of derivatives, and In vitro/In vivo polypharmacological profile evaluation of bioactive compounds”."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025